Expert Opinion on Drug Safety

Tamoxifen-induced non-alcoholic steatohepatitis: where are we now and where are we going?
pp. 1-4(4)
Authors: Osman, Khalid A; Osman, Meissa M; Ahmed, Mohamed H

Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analogues
pp. 5-7(3)
Authors: Kamal, Ali D; Bain, Stephen C

Do cheap internet drugs threaten the safety of the doctor-patient relationship?
pp. 9-13(5)
Authors: Bostwick, John Michael; Lineberry, Timothy W

The safety of asthma medications during pregnancy
pp. 15-26(12)
Authors: Källén, Bengt

Uses and complications of mitomycin C in ophthalmology
pp. 27-32(6)
Authors: Mearza, Ali A; Aslanides, Ioannis M

Is it safe to use topical NSAIDs for corneal sensitivity in Sjögren's syndrome patients?
pp. 33-43(11)
Authors: Aragona, Pasquale; Di Pietro, Rossana

The side effects of the prostaglandin analogues
pp. 45-52(8)
Authors: Holló, Gábor

Safety of topotecan in the treatment of recurrent small-cell lung cancer and ovarian cancer
pp. 53-62(10)
Author: Garst, Jennifer

Safety considerations for erythropoietin treatment in patients with cancer
pp. 63-69(7)
Author: Pirker, Robert

Prediction of drug-induced intrahepatic cholestasis: in vitro screening and QSAR analysis ofdrugs inhibiting the human bile salt export pump
pp. 71-86(16)
Authors: Sakurai, Aki; Kurata, Atsuo; Onishi, Yuko; Hirano, Hiroyuki; Ishikawa, Toshihisa

Safety Pharmacology Society: 6th Annual Meeting
pp. 87-92(6)
Author: Cavero, Icilio